179 related articles for article (PubMed ID: 35955563)
1. Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.
Doetsch DA; Ansari S; Jensen O; Gebauer L; Dücker C; Brockmöller J; Sachkova A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955563
[TBL] [Abstract][Full Text] [Related]
2. The mystery of the human proton-organic cation antiporter: One transport protein or many?
Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
[TBL] [Abstract][Full Text] [Related]
3. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
4. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
5. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
6. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
[TBL] [Abstract][Full Text] [Related]
7. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
Kitamura A; Higuchi K; Kurosawa T; Okura T; Kubo Y; Deguchi Y
Biol Pharm Bull; 2022; 45(10):1585-1589. PubMed ID: 36184519
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of pyrilamine-sensitive H~+/OC antiporter].
Wang XY; Zhang ZR
Yao Xue Xue Bao; 2016 Jun; 51(6):886-91. PubMed ID: 29878742
[TBL] [Abstract][Full Text] [Related]
11. Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB).
Sekhar GN; Georgian AR; Sanderson L; Vizcay-Barrena G; Brown RC; Muresan P; Fleck RA; Thomas SA
PLoS One; 2017; 12(3):e0173474. PubMed ID: 28362799
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
[TBL] [Abstract][Full Text] [Related]
13. Pyrilamine-sensitive proton-coupled organic cation (H
Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
[TBL] [Abstract][Full Text] [Related]
14. Proton-Coupled Organic Cation Antiporter Contributes to the Hepatic Uptake of Matrine.
Wu C; Sun X; Feng C; Liu X; Wang H; Feng F; Zhang J
J Pharm Sci; 2016 Mar; 105(3):1301-6. PubMed ID: 26886331
[TBL] [Abstract][Full Text] [Related]
15. Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.
Chapy H; Smirnova M; André P; Schlatter J; Chiadmi F; Couraud PO; Scherrmann JM; Declèves X; Cisternino S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539501
[TBL] [Abstract][Full Text] [Related]
16. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.
Terada T; Masuda S; Asaka J; Tsuda M; Katsura T; Inui K
Pharm Res; 2006 Aug; 23(8):1696-701. PubMed ID: 16850272
[TBL] [Abstract][Full Text] [Related]
18. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
Nies AT; Herrmann E; Brom M; Keppler D
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
[TBL] [Abstract][Full Text] [Related]
19. Atypical Substrates of the Organic Cation Transporter 1.
Redeker KM; Jensen O; Gebauer L; Meyer-Tönnies MJ; Brockmöller J
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36359014
[TBL] [Abstract][Full Text] [Related]
20. Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2.
Gebauer L; Jensen O; Brockmöller J; Dücker C
J Med Chem; 2022 Sep; 65(18):12403-12416. PubMed ID: 36067397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
